Droperidol-induced neuroleptic malignant syndrome

被引:7
|
作者
Edgar, J [1 ]
机构
[1] Royal Infirm, Dept Anaesthesia, Edinburgh EH3 9YW, Midlothian, Scotland
来源
HOSPITAL MEDICINE | 1999年 / 60卷 / 06期
关键词
D O I
10.12968/hosp.1999.60.6.1140
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:448 / 449
页数:2
相关论文
共 50 条
  • [1] NEUROLEPTIC MALIGNANT SYNDROME SECONDARY TO DROPERIDOL
    RATAN, DA
    SMITH, AHW
    BIOLOGICAL PSYCHIATRY, 1993, 34 (06) : 421 - 422
  • [4] Postoperative rhabdomyolysis due to neuroleptic malignant syndrome associated with droperidol and metoclopramide
    di Camillo Orfali, Guilherme
    Machado, Henrique Louzan
    Andrade, Pamela Vieira
    Santos, Joilson Moura
    Silva, Mary Santos
    do Amaral, Jose Luiz Gomes
    da Silva, Helga Cristina Almeida
    ANAESTHESIOLOGY INTENSIVE THERAPY, 2023, 55 (04) : 304 - 306
  • [5] CONDITIONED TOLERANCE TO HALOPERIDOL-INDUCED AND DROPERIDOL-INDUCED CATALEPSY
    NOWAK, K
    WELSCHKUNZE, S
    KUSCHINSKY, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1988, 337 (04) : 385 - 391
  • [6] NEUROLEPTIC-INDUCED CATATONIA - NEUROLEPTIC MALIGNANT SYNDROME
    DELEON, J
    SAIZRUIZ, J
    ALONSOABOLAFIA, A
    PICOSOLER, E
    MUNOZRUATA, J
    DELASERNA, I
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1990, 14 (01): : 129 - 136
  • [7] Neuroleptic-induced catatonia and neuroleptic malignant syndrome
    Lee, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 98 - 99
  • [8] Coronary artery spasm as a cause of droperidol-induced ventricular fibrillation
    Miyai, Nobuyuki
    Kawasaki, Tatsuya
    Sugihara, Hiroki
    Kayo, Ryotaro
    ANESTHESIA AND ANALGESIA, 2006, 103 (06): : 1602 - 1603
  • [9] Neuroleptic Malignant Syndrome Induced by Lamotrigine
    Ishioka, Masamichi
    Yasui-Furukori, Norio
    Hashimoto, Kojiro
    Sugawara, Norio
    CLINICAL NEUROPHARMACOLOGY, 2013, 36 (04) : 131 - 132
  • [10] Neuroleptic malignant syndrome induced by donepezil
    Matsumoto, T
    Kawanishi, C
    Isojima, D
    Iseki, E
    Kishida, I
    Kosaka, K
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 (01): : 101 - 103